Medical Services International Increases Sales Projections

EDMONTON, Alberta, July 9  /PRNewswire-FirstCall/ -- Medical Services International Inc. (Pink Sheets: MSITF) wishes to announce that its projected sales of VScan rapid test kits for the current year has increased. Previously it was projected that the Company would sell 3,800,000 VScan HIV test kits and 700,000 VScan TB test kits. The Company wishes to increase its previous projections for the current year of VScan HIV test kits to 4,200,000 kits and VScan TB test kits to 1,000,000 kits

These projections are based on existing orders, orders currently being negotiated and the number of kits that distributors must purchase in order to maintain their distributorships.  There have been several additional distributors added since the last projections

About VScan

The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, Malaria, West Nile, Syphilis and Prostate Cancer.

Medical Services International Inc. trades in the United States on the NQB Pink Sheets under the symbol "MSITF". For further information, please contact Robert Talbot at [phone] or http://www.medicalservicesintl.com/ or http://www.minerva-biotech.com/.

NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filing with regulatory bodies. 

DATASOURCE: Medical Services International Inc.



CONTACT: Robert Talbot of Medical Services International Inc.,

[phone]



Web site:  http://www.medicalservicesintl.com/

http://www.minerva-biotech.com/ 

Copyright